Skip to main content
. 2022 Jul 26;2022:3621496. doi: 10.1155/2022/3621496

Figure 5.

Figure 5

The therapeutic response role of the percentages of MDSCs and CD68+CD163+M2-like macrophages of NSCLC patients. (a, c) The percentages of CD68+CD163+M2-like macrophages of good and poor groups in pre-RT, RT, and post-RT. (b, d) The frequencies of MDSCs of good and poor in pre-RT, RT, and post-RT. (e, f) The correlation between MDSCs and CD68+CD163+M2-like macrophages of NSCLC patients of the good and poor groups during radiotherapy. #p < 0.05. Data were analyzed by Pearson's correlation test. The bars denote mean ± SD.